Trial intelligence / Profile preview

Comparative Study of TAP Block, Wound Infiltration, and Nalbuphine for C-Section Pain

NCT05276206Phase 1Completed

Sponsor
Egymedicalpedia
Start
Mar 2022
Primary completion
Mar 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 1, randomised trial of nalbuphine in postoperative pain (4 arms), sponsored by Egymedicalpedia. Primary endpoint: Post Operative Pain at 2 hours. Started Mar 2022; status: completed.

02

Drugs

nalbuphine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05276206.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05276206.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call